PALI – palisade bio, inc. (US:NASDAQ)
Stock Stats
News
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
Individual investors are Palisade Bio, Inc.'s (NASDAQ:PALI) biggest owners and were rewarded after market cap rose by US$70m last week [Yahoo! Finance]
Palisade Bio (NASDAQ:PALI) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
Form 8-K PALISADE BIO, INC. For: Dec 03
Form S-8 PALISADE BIO, INC.
Form 10-Q PALISADE BIO, INC. For: Sep 30
Form 4/A PALISADE BIO, INC. For: Oct 06 Filed by: Williams Donald Allen
Form 4/A PALISADE BIO, INC. For: Oct 06 Filed by: Wei Binxian
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.